Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.
Seek emergency medical treatment or contact the doctor in case of an overdose.
Thalidomide (severe)
Efavirenz (moderate)
Acarbose (moderate)
Lenalidomide (severe)
Carfilzomib (severe)
This medicine is used to relieve and treat the symptoms experienced after menopause. Most common symptoms include hot flashes and vaginal dryness.
This medicine is used to treat the deficiency of sex hormone due to delayed development of certain glands in females.
This medicine is used to treat certain symptoms in a patient suffering from end-stage cancer of the breast or prostate.
This medicine is used to treat vaginal bleeding which occurs beyond/irregular menstrual cycles.
This medicine is used to treat the symptoms of primary ovarian failure which results in low estrogen level in the body and infertility.
This medicine is used in the treatment of atrophic vaginitis, or vaginal atrophy, which is the thinning of the walls of the vagina caused by decreased estrogen levels.
This medicine is also used to prevent and treat the symptoms of osteoporosis in women who have reached menopause.
This medicine is also used for the management of symptoms of prostate cancer.
Body aches or Pain
Cough
Difficulty in breathing
Headache
Unusual tiredness or weakness
Dark urine (rare)
Vaginal discharge (rare)
Dizziness (rare)
This medicine is not recommended for use in patients who have a known allergy to estrogen products or any other inactive ingredients present in the formulation.
This medicine is not recommended for use if you have an abnormal episode of vaginal bleeding which was not diagnosed.
This medicine is not recommended for use in patients having a disease of the heart or blood vessels viz. deep vein thrombosis, recent heart attack, other blood clotting disorders, etc.
This medicine is not recommended for use in patients having breast cancer. It should also not be used if a patient has had breast cancer before or is suspected of having it. Patients having end-stage breast cancer and on palliative care are an exception here.
This medicine is not recommended for use in patients having an impairment of liver function owing to a disease or other contributing factors.
This medicine is not recommended for use in patients having cancer which is attributed to abnormal levels of the hormone estrogen in the body for a prolonged duration.